Recall archive / FDA drug enforcement
B-Complex, injection, 1 mL vials, Rx only, Cape Drugs 1384 Cape St. Claire Road Annapolis, MD 21409 — FDA record D-0284-2022
Reported terminated
Status as reported in the agency record. FDA warns that enforcement status may not track the current recall lifecycle; check the current official notice.
Source date Dec 3, 2021. Retrieved Oct 1, 2026. Last updated Oct 1, 2026.
Archive changed Oct 1, 2026. USDA FSIS records are unavailable; check FSIS directly. Source coverage and dates.
What the record says
- Product
- B-Complex, injection, 1 mL vials, Rx only, Cape Drugs 1384 Cape St. Claire Road Annapolis, MD 21409
- Reason
- Lack of Processing Controls
- Classification
- Class II
- Recalling firm
- Valgene Incorporated dba Cape Drugs
- Quantity
- 12 vials
- Agency-reported status
- Terminated
- Source record identifier
- D-0284-2022
What the recall classes mean. Classification is an agency assessment, not individual medical advice.
Lot and product identifiers
| Label field | Details supplied by the agency |
|---|---|
| Lot, code or applicability | Lot# 190036, BUD 12/27/2021 |
Match all identifying details in the current notice. A brand name alone is not enough.
Distribution
Maryland Only
States below are derived from the distribution text, including nationwide wording. They are not inferred from the firm's address.
Dates in the source
- Report date
- Dec 22, 2021
- Recall initiation date
- Dec 3, 2021
- Center classification date
- Dec 15, 2021
- Termination date
- Jan 4, 2022
FDA company pages use the listing date; enforcement records use initiation dates; CPSC uses recall date; NHTSA uses report-received date. These dates are not interchangeable.